Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
15.07.2025 12:12:43

EQS-News: Redcare Pharmacy’s CardLink solution for e-Rx redemption extended by gematik, enabling a smooth transition to the next generation technology. 

EQS-News: Redcare Pharmacy N.V. / Key word(s): Regulatory Approval
Redcare Pharmacy’s CardLink solution for e-Rx redemption extended by gematik, enabling a smooth transition to the next generation technology. 

15.07.2025 / 12:12 CET/CEST
The issuer is solely responsible for the content of this announcement.


Redcare Pharmacy’s CardLink solution for e-Rx redemption extended by gematik, enabling a smooth transition to the next generation technology. 

Sevenum, the Netherlands, 15 July 2025. Today Redcare Pharmacy was notified by its technology partner eHealth Experts that an extension until 31 January 2027 for its CardLink product license has been received. Redcare’s CardLink solution has been available in the Shop Apotheke app since May 2024, allowing patients in Germany to redeem their prescriptions digitally.

With the extension of its CardLink solution, Redcare’s access to the German e-prescription market continues and remains secured during the transition to the new Proof of Patient Presence (PoPP) infrastructure.

This next generation technology (PoPP) will continue to support electronic health card (eGK) redemption without PIN. Additionally, PoPP will provide an even higher standard of security and could offer more authentication options, such as biometric verification via Face ID or fingerprint. The new functionalities are expected to become available in late 2026.

Redcare Pharmacy’s CEO, Olaf Heinrich comments: “The extension of CardLink is a logical step for a smooth transition to the PoPP infrastructure. We are looking forward to the introduction of this new national standard, which will make prescription redemption even more convenient for patients.”

 

Investor Relations Contact:

Monica Ambrosi (Associate Director, Investor Relations)

investors@redcare-pharmacy.com

 

Press Contact:

Sven Schirmer (Director, Corporate Communications)

press@redcare-pharmacy.com

 

 

 

 

About Redcare Pharmacy

Originally founded in 2001, Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven.

As the one-stop pharmacy of the future, Redcare Pharmacy offers over 13 million active customers a wide range of more than 250,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands.

Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management.

Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. As of 19 June 2023, the company is a member of the MDAX selection index.

 



15.07.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: investors@redcare-pharmacy.com
Internet: www.redcare-pharmacy.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y072
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2169990

 
End of News EQS News Service

2169990  15.07.2025 CET/CEST

Analysen zu Redcare Pharmacy (ex Shop Apotheke)

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
11.07.25 Redcare Pharmacy Buy Jefferies & Company Inc.
07.07.25 Redcare Pharmacy Buy Jefferies & Company Inc.
04.07.25 Redcare Pharmacy Buy Deutsche Bank AG
03.07.25 Redcare Pharmacy Buy Baader Bank
03.07.25 Redcare Pharmacy Sell UBS AG
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

«Gold, kein Bonds!» – Thomas Wille über die richtige Strategie – zu Gast im BX Morningcall mit François Bloch

Thomas Wille, Chief Investment Officer bei Copernicus Wealth Management, ist seit über drei Jahrzehnten an den globalen Kapitalmärkten aktiv. Im exklusiven Interview mit dem BX Morning Call spricht er über seine Erfahrungen durch Finanzkrisen, neue Marktzyklen und die Kunst, Anlagestrategien langfristig erfolgreich umzusetzen.

Im aktuellen BX Morningcall begrüssen wir Investment Stratege François Bloch und David Kunz, COO der BX Swiss, Thomas Wille. Sie sprechen über die Bedeutung massgeschneiderter Investmentlösungen, den wachsenden Stellenwert alternativer Anlageklassen wie Gold, Private Markets und Krypto, sowie über die Herausforderungen in einem dynamischen Marktumfeld. Thomas Wille gibt Einblicke in seine Sicht auf die aktuelle Marktlage, seine Einschätzung zu Zinsen, Inflation, USD vs CHF – und er verrät, wie er persönlich investiert.

Ausserdem: Welche Rolle spielt Digitalisierung in der Vermögensverwaltung? Und welche Prinzipien sind heute entscheidend, um in der Vermögensverwaltung erfolgreich zu sein?

👉🏽 https://bxplus.ch/bx-musterportfolio/

«Gold, kein Bonds!» – Thomas Wille über die richtige Strategie – zu Gast im BX Morningcall mit François Bloch

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’404.46 19.22 BJ8SYU
Short 12’656.01 13.70 BOIS7U
Short 13’143.26 8.76 BDKS2U
SMI-Kurs: 11’901.32 15.07.2025 17:31:16
Long 11’401.93 19.22 BIYSFU
Long 11’170.81 13.94 B45S7U
Long 10’676.66 8.89 BUFSYU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}